Literature DB >> 26232730

Anti-inflammatory role of microglial alpha7 nAChRs and its role in neuroprotection.

Javier Egea1, Izaskun Buendia2, Esther Parada3, Elisa Navarro2, Rafael León3, Manuela G Lopez2.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are widely distributed throughout the central nervous system, being expressed in neurons and non-neuronal cells, where they participate in a variety of physiological responses like memory, learning, locomotion, attention, among others. We will focus on the α7 nAChR subtype, which has been implicated in neuroprotection, synaptic plasticity and neuronal survival, and is considered as a potential therapeutic target for several neurological diseases. Oxidative stress and neuroinflammation are currently considered as two of the most important pathological mechanisms common in neurodegenerative diseases such as Alzheimer, Parkinson or Huntington diseases. In this review, we will first analysed the distribution and expression of nAChR in mammalian brain. Then, we focused on the function of the α7 nAChR subtype in neuronal and non-neuronal cells and its role in immune responses (cholinergic anti-inflammatory pathway). Finally, we will revise the anti-inflammatory pathway promoted via α7 nAChR activation that is related to recruitment and activation of Jak2/STAT3 pathway, which on the one hand inhibits NF-κB nuclear translocation, and on the other hand, activates the master regulator of oxidative stress Nrf2/HO-1. This review provides a profound insight into the role of the α7 nAChR subtype in microglia and point out to microglial α7/HO-1 pathway as an anti-inflammatory therapeutic target.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alpha7 nAChR; HO-1; Inflammation; Jak2; Neuroprotection

Mesh:

Substances:

Year:  2015        PMID: 26232730     DOI: 10.1016/j.bcp.2015.07.032

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  76 in total

1.  Boosting Endogenous Resistance of Brain to Ischemia.

Authors:  Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Mol Neurobiol       Date:  2016-02-24       Impact factor: 5.590

Review 2.  Nicotinic acetylcholine receptors at the single-channel level.

Authors:  Cecilia Bouzat; Steven M Sine
Journal:  Br J Pharmacol       Date:  2017-04-08       Impact factor: 8.739

3.  The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain.

Authors:  Deniz Bagdas; Jenny L Wilkerson; Abhijit Kulkarni; Wisam Toma; Shakir AlSharari; Zulfiye Gul; Aron H Lichtman; Roger L Papke; Ganesh A Thakur; M Imad Damaj
Journal:  Br J Pharmacol       Date:  2016-07-18       Impact factor: 8.739

Review 4.  Nicotinic Acetylcholine Receptor Agonists for the Treatment of Alzheimer's Dementia: An Update.

Authors:  Justin L Hoskin; Yazan Al-Hasan; Marwan Noel Sabbagh
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

5.  Anti-inflammatory Silent Agonists.

Authors:  Nicole A Horenstein; Roger L Papke
Journal:  ACS Med Chem Lett       Date:  2017-09-26       Impact factor: 4.345

Review 6.  Molecular function of α7 nicotinic receptors as drug targets.

Authors:  Cecilia Bouzat; Matías Lasala; Beatriz Elizabeth Nielsen; Jeremías Corradi; María Del Carmen Esandi
Journal:  J Physiol       Date:  2017-11-29       Impact factor: 5.182

7.  Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.

Authors:  Roger L Papke; Clare Stokes; M Imad Damaj; Ganesh A Thakur; Khan Manther; Millet Treinin; Deniz Bagdas; Abhijit R Kulkarni; Nicole A Horenstein
Journal:  Br J Pharmacol       Date:  2017-06-08       Impact factor: 8.739

8.  The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.

Authors:  Giulia Donvito; Deniz Bagdas; Wisam Toma; Elnaz Rahimpour; Asti Jackson; Julie A Meade; Shakir AlSharari; Abhijit R Kulkarni; F Ivy Carroll; Aron H Lichtman; Roger L Papke; Ganesh A Thakur; M Imad Damaj
Journal:  Exp Neurol       Date:  2017-06-09       Impact factor: 5.330

Review 9.  Glial cells as therapeutic targets for smoking cessation.

Authors:  Mohit Kumar; Adewale Adeluyi; Erin L Anderson; Jill R Turner
Journal:  Neuropharmacology       Date:  2020-05-24       Impact factor: 5.250

Review 10.  Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.

Authors:  Zohara Sternberg
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.